Casdin Capital, LLC Gilead Sciences, Inc. Transaction History

Casdin Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $12.7 Million - $14.7 Million	-175,000 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $11 Million - $14 Million	175,000 New	175,000 $13.1 Million
Q2 2019 Aug 13, 2019	SELL	$61.87 - $69.38 $4.95 Million - $5.55 Million	-80,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $5 Million - $5.6 Million	80,000 New	80,000 $5.2 Million
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $2.19 Million - $2.66 Million	-30,000 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $2.13 Million - $2.51 Million	30,000	30,000 $2.15 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Casdin Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Casdin Capital, LLC with notifications on news.